The current role of secondary cytoreductive surgery for recurrent ovarian cancer

Ovarian cancer represents worldwide the second most frequent and the most fatal gynecological malignancy, with approximately two thirds of the patients presenting with advanced disease. Cytoreductive surgery, primary or after neoadjuvant chemotherapy, in combination with platinum-based chemotherapy...

Descripción completa

Detalles Bibliográficos
Autores principales: de Bree, Eelco, Michelakis, Dimosthenis, Anagnostopoulou, Elisavet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9633943/
https://www.ncbi.nlm.nih.gov/pubmed/36338689
http://dx.doi.org/10.3389/fonc.2022.1029976

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9633943/
https://www.ncbi.nlm.nih.gov/pubmed/36338689
http://dx.doi.org/10.3389/fonc.2022.1029976

Ejemplares similares